U.S. federal trademark · Serial No. 97253949 · Reg. No. 7844732
pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system
Scientific research and development services in the nature of platform technology, namely, development of immunotherapy platforms for the creation of CAR T-cells
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.